Stents

This channel includes news and new technology innovations for stents, also called vascular scaffolds. Stents are used to help prop open a vessel treated by balloon angioplasty because of the barotrauma caused by the extreme stretching of vessel walls. The stent enables to vessel to heal in an open position with collapsing. Drug eluting stents (DES) are coated in anti-proliferative drugs to precent scar tissue growth which can cause restenosis and occlude the vessel. DES require antiplatelet therapy because the drug carrier polymer on DES can cause thrombus inside the stent, even years after treatment, which is why bare metal stents are still used in some patients. This page includes news on coronary stents, carotid stents, peripheral stents, bioresorbable stents, and renal stents. 

News

May 8, 2007 - OBS Medical and Physio-Control Inc., a wholly-owned subsidiary of Medtronic Inc., announced they have ...

Home May 07, 2007
Home
Feature | Mark Paquin

Examples of physicians’ declining use of drug-eluting stents are growing.

According to Dr. Louis Cannon, Cardiac & ...

Home May 07, 2007
Home
Feature | Richard R. Rogoski

When it comes to treating patients suffering from heart failure, which is typically defined as a heart whose ...

Home May 07, 2007
Home
Feature | Richard R. Rogoski

In the simplest of terms, a ventricular assist device (VAD) is a battery-operated mechanical pump that helps a weakened ...

Home May 07, 2007
Home
News

May 7, 2007 — Citing issues related to potentially suboptimal therapeutic dosing of paclitaxel, Conor Medsystems, LLC ...

Home May 06, 2007
Home
News

April 30, 2007 — Carotid stenting can be performed on any age patient, but should be undertaken with caution and ...

Home April 29, 2007
Home
News

April 9, 2007 — MIV Therapeutics Inc. has announced that its recent bench test confirmed that merging Biosync Scientific ...

Home April 07, 2007
Home
News

April 9, 2007 — The drug used in Johnson & Johnson’s drug-eluting stent — produced by J&J-owned Cordis — does not ...

Home April 07, 2007
Home
Technology

The results of Boston Scientific's pivotal SPIRIT III clinical trial reaffirmed prior safety and efficacy data ...

Home March 27, 2007
Home
News

Boston Scientific Corp. announced two-year results from the TAXUS V In-Stent Restenosis (ISR) trial, demonstrating ...

Home March 25, 2007
Home
Technology

When used in conjunction with the ev3 embolic protection device, ev3’s PROTÉGÉ RX Carotid Stent has been FDA ...

Home March 22, 2007
Home
Technology


The FDA has granted clearance to the Cordis Endovascular division of Cordis Corp. to market its PRECISE RX ...

Home March 22, 2007
Home
Technology

When used in conjunction with the ev3 embolic protection device, ev3’s PROTÉGÉ RX Carotid Stent has been FDA cleared for ...

Home March 18, 2007
Home
News

March 9, 2007 — New studies show that about 60 percent of drug-eluting stents are used in off-label indications in the U ...

Home March 08, 2007
Home
News

Feb. 23, 2007 — Heart device maker Edwards Lifesciences Corp. received a warning this week from the FDA about the ...

Home February 22, 2007
Home
Subscribe Now